Last $108.16 USD
Change Today +3.39 / 3.24%
Volume 1.9M
VRTX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
As of 5:20 PM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stuart A. Arbuckle

Chief Commercial Officer and Executive Vice President , Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

48$4,819,022
As of Fiscal Year 2013

Background*

Mr. Stuart A. Arbuckle has been the Chief Commercial Officer and an Executive Vice President at Vertex Pharmaceuticals Incorporated since September 4, 2012. Mr. Arbuckle joined Vertex in September 2012 and oversees Vertex’s global commercial team, which is responsible for its sales, marketing, patient support, market research and other activities that support the approved use of Vertex’s two medicines. Mr. Arbuckle has more than 25 years of experience in leading global ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education
University of Leeds

Other Affiliations*

Annual Compensation*

Salary$553,846
Total Annual Compensation$553,846

Stock Options*

Restricted Stock Awards$544,988
All Other Compensation$12,675
Exercisable Options41,773
Exercisable Options Value$961,804
Unexercisable Options155,352
Unexercisable Options Value$3,174,140
Total Value of Options$4,135,943
Total Number of Options197,125

Total Compensation*

Total Annual Cash Compensation$1,196,521
Total Short Term Compensation$553,846
Other Long Term Compensation$557,663
Total Calculated Compensation$4,819,022
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $108.16 USD +3.39

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$876.9K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.